Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Synthon Pharmaceuticals Successfully Concluded Phase I Clinical Trial for Trastuzumab
Synthon Pharmaceuticals Successfully Concluded Phase I Clinical Trial for Trastuzumab
Synthon Pharmaceuticals Successfully Concluded Phase I Clinical Trial for Trastuzumab
Submitted by
admin
on March 25, 2012 - 12:39pm
Source:
Pipeline Review
News Tags:
Synthon Pharmaceuticals
trastuzumab
Herceptin
breast cancer
gastric cancer
biosimilars
Genentech
Headline:
Synthon Pharmaceuticals Successfully Concluded Phase I Clinical Trial for Trastuzumab
Do Not Allow Advertisers to Use My Personal information
